(MAPK) subgroups that are activated strongly by environmental stresses, are among several signaling mechanisms that have been implicated in the progression to hypertrophy. In particular, both kinase groups can be activated by mechanical strain and vasoactive peptides (4) (5) (6) (7) (8) . As with all MAPK signaling pathways, SAPKs and p38s are activated as part of three tiered MAPK-kinasekinase (MAP3K) ➝ MAPK-kinase (MKK) ➝ MAPK "core" signaling modules (5) . These core modules, in turn, are subject to multiple forms of regulation including activation by the trimeric G protein alpha subunits G α12 , G α13 , and G α16 , G αq , trimeric G protein βγ subunits (β 1 γ 1 ), as well as Rac and Cdc42, members of the Rho subfamily of Ras type GTPases. G α12 and G α13 , along with G αo , are putative effectors for angiotensin-II, a potent pro-hypertrophic vasoactive peptide (9) (10) (11) (12) (13) (14) (15) (16) (17) .
Support for the idea that the SAPKs and p38s are involved in hypertrophy comes from studies showing that expression in cardiomyocytes of constitutively active mutants of MKKs upstream of the SAPKs (SAPK/extracellular signal-regulated kinase (ERK) kinase-1, SEK1 and MKK7) or p38s, (MKKs-3 and-6) can induce hypertrophy in the absence of external stimulus (6, 7) . Moreover, expression of a dominant inhibitory, kinase-inactive form of SEK1 can completely block neonatal rat cardiomyocyte hypertrophy stimulated by endothelin, one of the most potent pro-hypertrophic agonists known (4) . Although the SAPK and p38 pathways may indeed be involved in the progression to hypertrophy, there is no clear picture of the molecular basis by which these stress pathways reprogram cells adapt to chronic stresses including those that cause hypertrophy.
The ability of the SAPKs and p38s to phosphorylate transcription factors and thereby trigger changes in gene expression is thought to underlie a substantial part of the mechanism by which these pathways affect cell function. Thus, the SAPKs and p38s are largely responsible for recruiting of the activator protein-1 (AP-1) transcription factor in response to stress (5, 18) . Key to dissecting the molecular mechanisms responsible for pathogenic stress responses such as hypertrophy is the identification of stress-induced genes that can sustain the prolonged activation of stress pathways and/or initiate the phenotypic changes characteristic of the responses to chronic stresses. 6 gene 33, encodes a polypeptide of previously unknown function. It has been established for some time that rat gene 33, like c-fos and c-jun, is an immediate-early gene that is rapidly induced by a heterologous array of mitogenic and stressful stimuli. The human isoform of gene 33, mig-6 , behaves in a similar manner (19) (20) (21) . Nevertheless, in spite of the extensive analysis of stimuli that induce gene 33, a possible physiologic function for Gene 33 has heretofore not been identified. Given the reported induction of gene 33 by stress, we sought to determine if prohypertrophic and chronic stress agonists could induce gene 33 transcription. In addition, we wished to begin to identify potential biochemical functions for the Gene 33 polypeptide. Our results show that gene 33 mRNA levels increase dramatically soon after the onset of diabetes, and continue to increase throughout the progression to diabetic nephropathy. By contrast, c-fos and cjun transcripts are detected in the kidney early in diabetes, but return to basal levels well before the onset of nephropathy. We also show that angiotensin-II and endothelin-1, potent pro-hypertrophic agonists in both the hypertensive heart and the diabetic kidney, can induce gene 33; and that mechanical strain, which is important to the pathology of cardiac and renal hypertrophy as well as ARDS (1) (2) (3) , induces gene 33 expression in a SAPK-dependent manner. This raises the possibility that expression of gene 33 could serve as a marker for chronic stress conditions such as incipient diabetic renal failure and, perhaps, the response to persistent environmental stresses such as those that precipitate ARDS.
The structure of the Gene 33 protein is suggestive of a molecular adapter that couples to Rho family GTPases. Two forms of Gene 33 are generated as a consequence of differential RNA splicing, a long form and a short form missing AAs 67-142. We demonstrate that the long Gene 33 polypeptide is cytosolic and can interact with Cdc42Hs in vivo and, in a GTP-dependent manner in vitro. Moreover, transient expression of the long form of Gene 33 results in the substantial and selective activation of the SAPKs. Our findings are the first to identify potential functions for the Gene 33 protein, and suggest that stress-induced expression of Gene 33 may serve to reprogram the cellular signaling machinery, in response to chronic stress, resulting in sustained activation of the SAPKs and, consequently, SAPK-dependent gene expression.
EXPERIMENTAL PROCEDURES
Plasmids, Constructs, Cells and Transfections--We used the following vectors: pEBG, a mammalian expression vector that expresses a glutathione-S-transferase (GST)-tagged polypeptide, pCMV5-FLAG, a mammalian expression vector that expresses an M2-FLAG-tagged polypeptide, pCMV5-Myc, a mammalian expression vector that expresses an Myc-tagged polypeptide, pMT3, a mammalian expression vector that expresses a hemagglutinin (HA)-tagged polypeptide and pGEX-KG, a bacterial expression vector that expresses a GST-tagged polypeptide. pCMV5-FLAG-and pGEX-KG-Cdc42Hs, pMT3-SAPK-p46β1, pMT3-p38α and pMT3-ERK1 have been described (22, 23) . The recombinant adenoviral construct encoding SEK1[K129R] has been described (4) . cDNA encoding 14-3-3ζ was kindly provided by Drs.
Guri Tzivion and Joseph Avruch (Massachusetts General Hospital). cDNA for ASK1 was kindly provided by Dr. Hidenori Ichijo (Tokyo Medical and Dental University). Gene 33 deletion constructs were generated by PCR and cloned, using standard methods (24) into various expression plasmids.
Human embryonic kidney 293 cells and murine NIH3T3 fibroblasts were transfected by the calcium phosphate method. Rat renal mesangial cells were prepared and cultivated as described (25) . Cells used were at passage three. A549 cells, a human pulmonary alveolar epithelial tumor cell line, were infected with the SEK1[K129R] adenovirus at the multiplicities of infection indicated in the figures. Mesangial cells were treated with human endothelin-1 (100 nM, 60 min), human angiotensin-II (500 nM, 60 min) or calcium ionophore (A23187, 1 µM, 60 min). For mechanical strain experiments, A549 cells were cultured on elastic surfaces. A flat piston, which is pushed upward in a cyclic fashion against the bottom of the elastic surface, produces uniform biaxial strain (26) . The rate of cyclic stretch was 12 cycles/min, and the degree of stretch was 5% for 2 hours. Unilateral nephrectomy was performed as described (27).
Streptozotocin Induction of Diabetes in Rats--Male
Protein Kinase Assays--SAPK, p38 and ERK1 immune complex kinase assays were performed as described (23) . 293 cells were transfected with 1 µg pMT3-SAPK, p38 or ERK1 and either empty plasmid, or pCMV5-FLAG-Gene 33.
After cell lysis, kinases were immunoprecipitated with anti HA.
Coimmunoprecipitation Assays--In vivo associations between Gene 33 and various proteins were performed as described (28) . In vitro association of Gene 33 and Cdc42Hs was performed as follows. GST-Cdc42Hs was expressed in E. coli, purified on glutathione (GSH) agarose, eluted with free GSH and stored as described (29) . For re-immobilization and nucleotide charging, purified GST-Cdc42Hs was then normalized to 1 mg/ml in GSH Sepharose binding buffer (20 mM Hepes, pH 7.4, 100 mM NaCl, 5 mM MgCl 2 , 2 mM DTT, 20% (v/v) glycerol), and 500 µl of protein was added per 50 µl (settled) aliquot of glutathione agarose. After one hour of rotating at 4˚C, the slurry was washed twice in nucleotide depletion buffer (20 mM Hepes, pH 7.4, 10 mM EDTA, 1 mM DTT, 50 mM NaCl, 5% (v/v) glycerol, 0.1% (w/v) Triton X-100).
GST-Cdc42Hs beads were then loaded with GTP-γS or GDP-βS as follows. 50 µl beads were incubated with 1 ml nucleotide loading buffer (20 mM Hepes, pH 7.4, 50 mM NaCl, 10 mM (v/v) glycerol, 50 mM NaCl, 50 mM β-glycerophosphate, 1 mM EGTA, 1% (w/v) Triton X-100,
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GDP-βS at a final concentration of 0.2 mM. Charged Cdc42Hs was pelleted by centrifugation and the supernatant removed and 1 ml of the cognate (GTP-γS or GDP-βS-supplemented) cell extract was added. After two hours at 4˚C, the beads were washed with the relevant (GTP-γS or GDP-βS-supplemented) nucleotide loading buffer. Polypeptides bound to the GST-Cdc42Hs were detected by SDS-PAGE and immunoblotting with anti-FLAG.
Miscellaneous methods--Northern blotting was performed as described (24) .
Immunofluorescence analysis of Gene 33 localization was performed as described (30) .
RESULTS

Transcriptional Induction of gene 33 in Response to Environmental Stress--Transcription
of gene 33 is known to occur in response to insulin, growth factors and some stresses (19) . We wished to confirm and extend the hypothesis that gene 33 was induced in response to environmental stress. Cultures of rat glomerular mesangial cells were subjected to hypertonic shock (500 mM sorbitol) for 20 min, at which time, the medium was returned to iso-osmotic conditions. Total cellular RNA was prepared immediately after the 20 min stimulus, and for various times up to four hours after the cessation of stimulus, and used for Northern analysis of gene 33 expression. As is apparent in Fig. 1 Similarly, expression of two other immediate-early genes, c-jun and c-fos, was stimulated at this early time point ( Fig. 2A) . Expression of c-fos continued to increase and was maximal by 41
hours after the onset of diabetes, declining thereafter; by contrast, c-jun expression remained constant for up to 46 hours after the onset of diabetes.
Unilateral nephrectomy is associated with immediate-early gene expression and correlates with a transient compensatory hypertrophy in the remaining kidney (1). Unilateral nephrectomy, in nondiabetic animals, produced a striking induction of gene 33, within 17 hours, in the remaining kidney. In parallel, c-jun expression in the remaining kidney was also strongly stimulated. c-fos induction was observed, but was less robust than that incurred by diabetes. gene 33 and c-jun, but not c-fos expression was greater in unilaterally nephrectomized, diabetic animals than in animals subjected to either treatment alone ( Fig. 2A ).
We allowed some of the streptozotocin-injected animals to progress, over five weeks, to frank diabetic nephropathy--a point at which they displayed overt proteinuria and, as determined by concentrations. This calcium influx is important to signaling by these vasoactive peptides (31).
Induction of gene 33 by Vasoactive Peptides and Mechanical Strain in Renal and Pulmonary Cells Points to a Role in the General Stress Response: Expression of gene 33 in Response to
Mechanical Strain is SAPK-dependent--The
The calcium ionophore A23187 also vigorously induces expression of gene 33 and c-jun, suggesting that agonists which induce increases in intracellular calcium also induce gene 33 expression (Fig. 3A) .
Cyclical mechanical stretching of A549 pulmonary epithelial cells cultured on an elastic surface (see Experimental Procedures) is a facile cellular model for the mechanical strain incurred by inappropriately controlled mechanical ventilation (3). Mechanical stretching also mimics the features of the strain that may occur at the mesangial cell membrane with glomerular hypertension, or in cardiomyocytes with pressure overload (7, 31) . Cyclical mechanical stretching of A549 pulmonary epithelial cells also causes a substantial induction of gene 33 (Fig. 3B ).
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The promoter for gene 33 contains a consensus tetradecanoyl phorbol ester response element (TRE) at position -476 relative to the transcriptional start site (19, 20) . The TRE is a cis acting element which binds AP-1 and trans activates genes in response to stimuli that recruit AP-1 and Cdc42Hs. By contrast, although we were also able, in overexpression experiments, to detect in vivo associations between Gene 33 and both Rac1 and Ras (but not RhoA), these interactions either did not occur, or were not GTP-dependent in vitro (data not shown).
From Fig. 5E it is also evident that PAK1 binds more strongly to Cdc42Hs than does Gene 33. In the experiments shown in Fig. 5E (Fig. 5E, right) , is the binding of Gene 33 to Cdc42Hs equal to that of PAK1. It is noteworthy that the levels of Gene 33 present in the cell are subject to change, in response to environmental stimuli (Figs. 1-4 and Ref. 19) , and Gene 33 levels become quite substantial as animals progress to diabetic nephropathy (Fig. 2B) . effectors. Such levels might only be attained after prolonged stress (Fig. 2B ). vigorously activated p38 (Fig. 6A) . We conclude, therefore, that with regard to mammalian MAPK pathways, Gene 33 is a selective activator of the SAPKs.
Selective Activation of the SAPKs by Gene 33--The
Deletion studies of the Gene 33 polypeptide reveal that expression of the carboxyl terminal half of the molecule (AAs 819-459), devoid of the CRIB motif, but containing the 14-3-3 binding sites as well as the AH domain and the putative PDZ binding site (Fig. 6B) , is both necessary and sufficient for activation of the SAPK pathway (Fig. 6C) . Thus, we refer to this portion of the Gene 33 polypeptide as the effector region.
By contrast, the amino terminal half of the protein, including the CRIB and SH3 binding domains ( Fig. 6B ) is insufficient for SAPK pathway activation (Fig. 6C) . We also observe that Gene 33 (or the carboxyl terminal half of Gene 33) and V12-Cdc42Hs, when coexpressed, activate SAPK synergistically (Fig. 6C) . Curiously, however, expression of the Gene 33 CRIB motif does not block SAPK activation by V12-Cdc42Hs (Fig. 6C) , perhaps due to the redundancy of mechanisms by which Cdc42 is thought to recruit the SAPKs (44, 46), and the comparatively low affinity of Gene 33 for Cdc42 (Fig. 5E ).
The experiments in Figs. 5-6C employed the long form of Gene 33, and deletions thereof.
We next wished to ascertain the biochemical properties of the short Gene 33 polypeptide encoded by the alternatively spliced gene 33 mRNA. This deletion does not remove any of the Gene 33 effector sequences shown in Fig 6C to Expression of active Cdc42Hs is known to activate the SAPK and p38 pathways (15) (16) (17) .
Still, it is unclear from our results if Gene 33 provides a mechanism whereby Cdc42Hs could recruit the SAPKs. Although Gene 33 binding to Cdc42Hs is GTP-dependent, the strength of this interaction is considerably lower than that between Cdc42Hs and PAK1, and expression of the Gene 33 CRIB motif does not significantly hamper activation of the SAPKs by V12-Cdc42Hs.
Taken together, these results suggest that for Gene 33 to be a true Cdc42Hs effector with regard to SAPK activation, its levels in the cell must be sufficiently high to permit appreciable binding to The homology between the Gene 33 AH domain and the noncatalytic carboxyl terminus of Ack1 is striking, and it is possible that similar target recruitment mechanisms are employed by Ack and Gene 33 may activate additional pathways that have yet to be identified. Given that the SAPK pathway has been implicated in hypertrophy (4, 6) , it is plausible to speculate that sustained Gene 33-dependent SAPK pathway activation, arising as a consequence of hypertension or diabetes, may trigger the cell to initiate hypertrophy. The numbers indicate the hours elapsed between the treatment (nephrectomy, streptozotocin or both) and harvest of the kidney. B Same as (A), except that the animals were allowed to proceed to frank diabetic renal failure (five weeks post streptozotocin injection). In these assays, unilateral nephrectomy was not performed, and only the effects of diabetes on gene expression were tested.
FIGURE LEGENDS
The blots were probed for glyceraldehyde-3-phosphate dehydrogenase (gapdh) expression as a loading control. by guest on October 1, 2017
